enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
2.410
+0.130 (5.70%)
At close: Nov 13, 2026, 4:00 PM EST
2.319
-0.091 (-3.78%)
After-hours: Nov 13, 2026, 7:58 PM EST
enGene Therapeutics Employees
As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year. That makes enGene Therapeutics the 32,637th largest employer in the world and 4,234th in the United States.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,589,756
Market Cap
161.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
| Jul 31, 2023 | 33 | - | - | 33 | 0 |
| Apr 30, 2023 | 33 | - | - | 30 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Molecular Partners AG | 134 |
| Foghorn Therapeutics | 106 |
| Immunic | 100 |
| LENZ Therapeutics | 40 |
| Jyong Biotech | 27 |
| Spruce Biosciences | 25 |
| Outlook Therapeutics | 17 |
ENGN News
- 21 hours ago - Leerink upgrades enGene to Outperform as worst-case scenario off the table - TheFly
- 23 hours ago - enGene upgraded to Outperform from Market Perform at Leerink - TheFly
- 1 day ago - Piper Sandler upgraded enGene to Overweight on updated LEGEND data - TheFly
- 1 day ago - enGene upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 2 days ago - enGene upgraded to Overweight from Equal Weight at Wells Fargo - TheFly
- 2 days ago - enGene Therapeutics Transcript: Study update - Transcripts
- 2 days ago - enGene Therapeutics Press release: Study update - Filings
- 2 days ago - enGene Therapeutics Slides: Study update - Filings